On the recordMarch 1, 2017
some brand drug manufacturers are using REMS programs to delay competition
Source
congress.govsome brand drug manufacturers are using REMS programs to delay competition
Pallone highlights misuse of REMS by brand manufacturers to hinder generics.
Share
More from Frank Pallone
The most common cancer in the United States is skin cancer, with at least one in five Americans developing it during their lifetime.
To meet completely reasonable demands for health care and due process under the Constitution with violence is unacceptable.
The Congressional Award is given to individuals whose accomplishments and dedication to their communities exemplifies the best qualities of the future.